Detection of Hepatic Fibrogenesis: A Review of Available Techniques

References

• Desmet VJ. Fibrosis of the liver: a pathologist's view. Proceedings of the 71st Falk Symposium, Fat Storing Cells and Liver Fibrosis, C Surrenti, A Casini, S Milani, M Panzani. Kluwer Academic Publishers, Florence, Italy. Lancaster 1–3 July, 1993; 1994, 257–73
   Google Scholar
• James J, Bosch K S, Aronson D C, Houtkooper JM. Sirius red histophotometry and spectrophotometry of sections in the assessment of the collagen content of liver tissue and its application in growing rat liver. Liver 1990; 10: 1–5
   PubMedGoogle Scholar
• Knodell R G, Ishak K G, Black W C, Chen T S, Craig R, Kaplowits N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431–5
   PubMed Web of Science ®Google Scholar
• Desmet V J, Gerber M, Hoofnagle J H, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513–20
   PubMed Web of Science ®Google Scholar
• Chevallier M, Guerret S, Chossegros P, Gerard F, Grimaud JA. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 1994; 20349–55
   Google Scholar
• Leon A LD, Rojkind M. A simple micromethod for collagen and total protein, determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 1985; 33: 737–43
   PubMed Web of Science ®Google Scholar
• Martinez-Hernandez A, Amenta PS. Morphology, location, and origin of hepatic extracellular matrix. Extracellular matrix, chemistry, biology and pathobiology with emphasis on the liver, M A Zern, L M Reid. Marcel Dekker, Inc, New York 1993; 255–327
   Google Scholar
• Schuppan D, Herbst H, Milani S. Matrix, matrix synthesis and molecular networks in hepatic fibrosis. Extracellular matrix, chemistry, biology and patho-biology with emphasis on the liver, M A Zern, L M Reid. Marcel Dekker, Inc, New York 1993; 201–54
   Google Scholar
• Jezequel A M, Ballardini G, Mancini R, Paolucci F, Bianchi F B, Orlandi F. Modulation of extracellular components during dimethylnitrosamine-induced cirrhosis. J Hepatol 1990; 11: 206–14
   PubMed Web of Science ®Google Scholar
• Clément B, Levavasseur F, Loréal O, Lietard J, L'Helgoualc'h A, Guillouzo A. Role of hepatocytes and Ito cells in the synthesis and deposition of extracellular matrix. Proceedings of the 71st Falk Symposium, Fat Storing Cells and Liver Fibrosis, C Surrenti, A Casini, S Milani, M Pinzani. Kluwer Academic Publishers, Florence, Italy. Lancaster 1–3 July, 1993; 1994, 13–22
   Google Scholar
• Takahara T, Kojima T, Miyabayashi C, House K, Sasaki H, Muragaki Y, et al. Collagen production in fat-storing cells after carbon tetrachloride intoxication in the rat. Immunoelectron microscopy observation of type I, type III collagens and prolyl hydroxylase. Lab Invest 1988; 59: 509–21
   PubMed Web of Science ®Google Scholar
• Fujiwara K, og ata I, Ohta Y, Hayashi S, Mishiro S, Takatsuki K, et al. Decreased collagen accumulation by a prolyl hydroxylase inhibitor in pig serum-induced fibrotic rat liver. Hepatology 1988; 8: 804–7
   PubMed Web of Science ®Google Scholar
• Loréal O, Clément B, Schuppan D, Rescan P Y, Rissel M, Guillouzo A. Distribution and cellular origin of collagen type VI during development and in cirrhosis. Gastroenterology 1992; 102: 980–7
   PubMed Web of Science ®Google Scholar
• Loréal O, Levavasseur F, Fromaget C, Gros D, Guillouzo A, Clément B. Cooperation of Ito cells and hepatocytes in the deposition of an extracellular matrix in vitro. Am J Pathol 1993; 143: 583–44
   Google Scholar
• Casini A, Ceni E, Salzano R, Schuppan D, Milani S, Pellegrini G, et al. Regulation of undulin synthesis and gene expression in human fat-storing cells by acetaldehyde and transforming growth factor-β1: comparison with fibronectin. Biochem Bio-phys Res Commun 1994; 199: 1019–26
   PubMedGoogle Scholar
• Milani S, Grappone C, Pellegrini G, Schuppan D, Herbst H, Calabro A, et al. Undulin RNA and protein expression in normal and fibrotic human liver. Hepatology 1994; 20: 908–16
   PubMedGoogle Scholar
• Schwoegler S, Neubauer K, Knittel T, Chung A E, Ramadori G. Entactin gene expression in normal and fibrotic rat liver and rat liver cells. Lab Invest 1994; 70: 525–36
   PubMed Web of Science ®Google Scholar
• Ramadori G, Schwoegler S, Veit T, Rieder H, Chiquet-Ehrismann R, Mackie EI, et al. Tenascin gene expression in rat liver and in rat liver cells, in vivo and in vitro studies. Virchows Arch [Cell Pathol] 1991; 60: 145–53
   Google Scholar
• Miyazaki H, Van Eyken P, Roskams T, De Vos R, Desmet VJ. Transient expression of tenascin in experimentally induced cholestatic fibrosis in rat liver: an immunohistochemical study. J Hepatol 1993; 19: 353–66
   PubMedGoogle Scholar
• Bissell M D, Friedman S L, Maher J J, Roll FG. Connective tissue biology and hepatic fibrosis: report of a conference. Hepatology 1990; 11: 488–98
   PubMed Web of Science ®Google Scholar
• Gressner AM. Perisinusoidal lipocytes and fibrogenesis. Gut 1994; 35: 1331–3
   PubMed Web of Science ®Google Scholar
• Ballardini G, Faccani A, Fallani M, Berti S, Vasi V, Castaldini C, et al. Sequential behaviour of extracellular matrix glycoproteins in an experimental model of hepatic fibrosis. Virchows Arch [Cell Pathol] 1985; 49: 317–24
   Google Scholar
• MiaO S, Suri P K, Shu-Ling L, Abraham A, Cook N, Zern MA. Role of the cyclic AMP response element in rat fibronectin gene expression. Hepatology 1993; 17: 882–90
   PubMedGoogle Scholar
• Murawaki Y, Koda M, Yamada S, Yamada S, Kawasaki H, Shima H, et al. Serum collagenase activity in patients with chronic liver disease. J Hepatol 1993; 18: 328–34
   PubMed Web of Science ®Google Scholar
• Arthur M JP. Matrix degradation in the liver. Proceedings of the 71st Falk Symposium, Fat Storing Cells and Liver Fibrosis, C Surrenti, A Casini, S Milani, M Pinzani. Kluwer Academic Publishers, Florence, Italy. Lancaster 1–3 July, 1993; 1994, 110–27
   Google Scholar
• Ruwart M J, Wilkinson K F, Rush B D, Vidmar T J, Peters K M, Henley KS. The integrated value of serum procollagen III peptide (PIIINP) over time predicts hepatic hydroxyproline content and stainable collagen in a model of dietary cirrhosis in the rat. Hepatology 1989; 10: 801–6
   PubMed Web of Science ®Google Scholar
• Wu J, Danielsson A. Inhibition of hepatic fibrogenesis: a review of pharmacological candidates. Scand J Gastroenterol 1994; 29: 385–91
   PubMed Web of Science ®Google Scholar
• Gabrielli G B, Corrocher R. Hepatic fibrosis and serum markers: a review. Dig Dis 1991; 9: 303–16
   PubMedGoogle Scholar
• Murawaki Y, Kato S, Hirayama C. Hepatic collagen synthesis in patients with alcoholic and nonalcoholic liver disease. Gastroenterol Jpn 1991; 26: 465–47
   PubMedGoogle Scholar
• Milani S. Expression of extracellular matrix components in normal and fibrotic liver. Proceedings of the 71st Falk Symposium, Fat Storing Cells and Liver Fibrosis, C Surrenti, A Casini, S Milani, M Pinzani. Kluwer Academic Publishers, Florence, Italy. Lancaster 1–3 July, 1993; 1994, 37–54
   Google Scholar
• Zern M A, Czaja M J, Weiner FR. The use of molecular hybridization techniques as tools to evaluate hepatic fibrogenesis. Connective tissue in health and disease, M Rojkind. CRC Press, Boca Raton (FL) 1990; Vol. 1: 99–122
   Google Scholar
• Kresina T F, He Q, Degli Esposti S, Zern MA. Gene expression of transforming growth factor β1 and extracellular matrix proteins in murine Schistosoma mansoni infection. Gastroenterology 1994; 107: 773–80
   PubMed Web of Science ®Google Scholar
• Maher J J, Bissell DM. Cell-matrix interactions in liver. Semin Cell Biol 1993; 4: 198–201
   Google Scholar
• Friedman SL. The cellular basis of hepatic fibrosis: mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828–35
   PubMed Web of Science ®Google Scholar
• Okuno M, Muto Y, Kato M, Moriwaki H, Noma A, Yagaya Q, et al. Changes in serum and hepatic levels of immunoreactive prolyl hydroxylase in two models of hepatic fibrosis in rats. J Gastroenterol Hepatol 1991; 6: 271–7
   PubMedGoogle Scholar
• Murawaki Y, Kusakabe Y, Hirayama C. Serum lysyl oxidase activity in chronic liver diseases in comparison with serum levels of prolyl hydroxylase and laminin. Hepatology 1991; 14: 1167–73
   PubMed Web of Science ®Google Scholar
• Jiang Z, You D Y, Chen X C, Wu J. Monitoring of serum markers of fibrosis during CC4-induced liver damage—effects of anti-fibrotic agents. J Hepatol 1992; 16: 282–9
   PubMed Web of Science ®Google Scholar
• Savolainen E R, Brocks D, Ala-Kokko L, Kivirikko KI. Serum concentrations of the N-terminal propeptide of type III procollagen and two type IV collagen fragments and gene expression of the respective collagen types in liver in rats with dimethylnitrosamine-induced hepatic fibrosis. Biochem J 1988; 249: 753–7
   PubMed Web of Science ®Google Scholar
• Hayasaka A, Koch J, Schuppan D, Maddrey W C, Hahn EG. The serum concentration of the aminoterminal propeptide of procollagen type III and the hepatic content of mRNA for the α1 chain of procollagen type III in carbon tetrachloride-induced rat liver fibrogenesis. J Hepatol 1991; 13: 328–38
   PubMedGoogle Scholar
• Schuppan D. Connective tissue polypeptides in serum as parameters to monitor anti-fibrotic treatment fibrogenesis. J Hepatol 1991; 13: S17–25, Suppl 3
   Web of Science ®Google Scholar
• Gabrielli G B, Faccioli G, Casaril M, Capra F, Bonaui L, Falezza G, et al. Procollagen III peptide and fibronectin in alcoholic related chronic liver disease: correlation with morphological features and biochemical tests. Clin Chim Acta 1989; 179: 315–22
   PubMedGoogle Scholar
• Ramadori G, Mohrens G, Manns M, Rieder H, Dienes H P, Hess G, et al. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. Eur J Clin Invest 1991; 21: 323–30
   PubMed Web of Science ®Google Scholar
• Floreani A, Zappala F, Mazzetto M, Naccarato R, Plebani M, Chiaramonte M. Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease. Dig Dis Sci 1994; 39: 9–14
   PubMed Web of Science ®Google Scholar
• Mutimer D L, Bassendine M F, Kelly P, James O FW. Is measurement of type III procollagen amino propeptide useful in primary biliary cirrhosis?. J Hepatol 1989; 9: 184–9
   PubMedGoogle Scholar
• Davis B H, Madri JA. Type I and type III procollagen peptides during hepatic fibrogenesis, an immunohistochemical and ELISA serum study in the CCl4 rat model. Am J Pathol 1987; 126: 137–47
   PubMedGoogle Scholar
• McCullough A, Stassen W N, Weisseer R H, Czaja AZ. Serum type III procollagen peptide concentration in severe chronic active hepatitis: relationship to cirrhosis and disease activity. Hepatology 1987; 7: 49–54
   PubMed Web of Science ®Google Scholar
• Trinchet J C, Hartmann D J, Pateron D, Laarif M, Callard P, Ville G, et al. Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis, relationship to liver histology and conventional liver tests. J Hepatol 1991; 12: 139–44
   PubMedGoogle Scholar
• Trivedi P, Cheeseman P, Portman B, Mowat AP. Serum type III procollagen peptide as a non-invasive marker of liver damage during infancy and childhood in extrahepatic biliary atresia, idiopathic hepatitis of infancy and α1 antitrypsin deficiency. Clin Chim Acta 1986; 161: 137–46
   PubMedGoogle Scholar
• Bentsen K D, Henriksen F, Bendtsen F, Horslev-Petersen K, Lorenzen I. Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and patients with alcoholic cirrhosis. Hepatology 1990; 11: 957–63
   PubMed Web of Science ®Google Scholar
• Smedsred B, Pertoft H, Gustafson S, Laurent TC. Scavenger functions of liver endothelial cells. Biochem J 1990; 266: 313–27
   PubMedGoogle Scholar
• Melkko J, Hellevik T, Risteli L, Risteli J, Smedsrød B. Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells. J Exp Med 1994; 179: 405–12
   PubMed Web of Science ®Google Scholar
• Fleischmann R, Michel R, Wienbeck M, Renk I. Procollagen III peptide in liver metastases. Proceedings of International Falk Symposium, Molecular and Cell Biology of Liver Fibrogenesis, A M Gressner, G Ramadori. Kluwer Academic Publishers, Marburg, Germany. Lancaster 22–23 January, 1992; 1992, 538–44
   Google Scholar
• Savolainen E R, Goldberg B, Leo M A, Velez M, Lieber CS. Diagnostic value of serum procollagen peptide measurements in alcoholic liver disease. Alcohol Clin Exp Res 1984; 8: 384–9
   PubMed Web of Science ®Google Scholar
• Nitsu Y, Koda K, Ito N, Owada M, Morita K, Watanabe N, et al. Measurement of carboxyl terminal peptide of type I procollagen in sera of patients with viral hepatitis and liver cirrhosis. J Gastroenterol Hepatol 1988; 3: 159–67
   Google Scholar
• Shahin M, Schuppan D, Waldherr R, Risteli J, Risteli L, Savolainen E R, et al. Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease. Hepatology 1992; 15: 637–44
   PubMed Web of Science ®Google Scholar
• Calcado A, Trivedi P, Portmann B, Mowat AP. Serum concentrations of extracellular matrix components: novel markers of metabolic control and hepatic pathology in glycogen storage disease. J Pediatr Gastroenterol Nutr 1991; 13: 1–9
   PubMedGoogle Scholar
• Hayasaka A, Schuppan D, Ohnishi K, Okuda K, Hahn EG. Serum concentrations of the carboxylterminal cross-linking domain of procollagen type IV (NCl) and the aminoterminal propeptide of procollagen type III (PIIINP) in chronic liver disease. J Hepatol 1990; 10: 17–22
   PubMedGoogle Scholar
• Yamada S, Suou T, Kawasaki H, Yoshikawa N. Clinical significance of serum 7s collagen in various liver diseases. Clin Biochem 1992; 25467–70
   Google Scholar
• Chung AE. Laminin. Extracellular matrix, chemistry, biology and pathobiology with emphasis on the liver, M A Zern, L M Reid. Marcel Dekker, Inc, New York 1993; 25–48
   Google Scholar
• Kropf J, Gressner A M, Negwer A. Efficacy of serum laminin measurement for diagnosis of fibrotic liver diseases. Clin Chem 1988; 34: 2026–30
   PubMed Web of Science ®Google Scholar
• Felden F, Renkes P, Fremont S, Chambre J F, Champigneulle B, Gaucher P, et al. Serum laminin P1 in metastatic colon carcinoma. Clin Chem 1991; 37(10, Pt 1)1795–6
   PubMedGoogle Scholar
• Gressner A M, Tittor W, Kropf J. The predictive value of serum laminin for portal hypertension in chronic liver diseases. Hepatogastroenterology 1988; 35: 95–100
   PubMedGoogle Scholar
• Gressner AM. Liver fibrosis: perspectives in pathobiochemical research and clinical outlook. Eur J Clin Chem Clin Biochem 1991; 29: 293–311
   PubMedGoogle Scholar
• Kropf J, Gressner A M, Tittor W. Logistic-regression model for assessing portal hypertension by measuring hyaluronic acid (hyaluronan) and laminin in serum. Clin Chem 1991; 37: 30–5
   PubMed Web of Science ®Google Scholar
• Engström-Laurent A, Laurent A BG, Lilja K, Laurent TC. Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest 1985; 45: 497–504
   PubMed Web of Science ®Google Scholar
• Gibson P R, Fraser R E, Brown T J, Finch C F, Jones P A, Colman J C, et al. Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease. Hepatology 1992; 15: 1054–9
   PubMed Web of Science ®Google Scholar
• Guéchot J, Poupon R E, Giral P, Balkau B, Giboudeau J, Poupon R. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. J Hepatol 1994; 20: 388–93
   PubMed Web of Science ®Google Scholar
• Poupon R E, Balkau B, Gu Cchot J, Heintzmann F. Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue. Hepatology 1994; 19: 635–40
   PubMed Web of Science ®Google Scholar
• Bolarin DM. Liver collagen glucosyltransferase in experimental primary liver carcinoma. Acta Physiol Hung 1991; 77: 113–20
   PubMedGoogle Scholar
• Ueno T, Inuzuka S, Torimura T, Oohira H, Ko H, Obata K, et al. Significance of serum type IV collagen levels in various liver diseases, measurement with a one-step sandwich enzyme immunoassay using monoclonal antibodies with specificity for pepsin-solubilized type IV collagen. Scand J Gastroenterol 1992; 27: 513–20
   PubMed Web of Science ®Google Scholar
• Ricard-Blum S, Bresson-Handi S, Vuitton D-A, Ville G, Grimaud JA. Hydroxy-pyridimiun collagen cross-links in human liver fibrosis: a study of alveolar echinococcosis. Hepatology 1992; 15: 599–602
   PubMed Web of Science ®Google Scholar
• Ricard-Blum S, Ville G, Grimaud JA. Pyridinoline, a mature collagen cross-link, in fibrotic liver from Schistosoma mansoni-infected mice. Am J Trop Med Hyg 1992; 47: 816–20
   PubMed Web of Science ®Google Scholar
• Inuzuka S, Ueno T, Torimura T, Tamaki S, Sakata R, Sata M, et al. Vitronectin in liver disorders: biochemical and imrnunohistochemical studies. Hepatology 1992; 15: 629–36
   PubMedGoogle Scholar
• Kobayashi J, Yamada S, Kawasaki H. Distribution of vitronectin in plasma and liver tissue: relationship to chronic liver disease. Hepatology 1994; 20: 1412–7
   PubMedGoogle Scholar
• Li P, Jiang B B, Zhang L B, Liu C, Xu L M, Xue H M, et al. Direct measurement of hepatic neutral collagenase activity and the significance of the method in studying hepatofibrosis. Chin J Pathophysiol 1989; 5: 566–9
   Google Scholar
• Myara I, Miech G, Fabre M, Mangeot M, Lemonnier A. Changes in prolinase and prolidase activity during CCl4 administration inducing liver cytolysis and fibrosis in rat. Br J Exp Pathol 1987; 68: 7–13
   PubMed Web of Science ®Google Scholar
• Zuyderhoudt F MJ, Bruman A M, Smit J JH, Jong LD. Plasma prolidase in the rat: no index of the liver fibrosis. Clin Chem 1985; 31: 662
   PubMedGoogle Scholar
• Li J-J, Rosman A S, Leo M A, Nagai Y, Lieber CS. Tissue inhibitor of metalloproteinase is increased in the serum of marker of fibrosis. Hepatology 1994; 19: 1418–23
   PubMedGoogle Scholar